Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Titel:
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Auteur:
Pujade-Lauraine, Eric Fujiwara, Keiichi Ledermann, Jonathan A Oza, Amit M Kristeleit, Rebecca Ray-Coquard, Isabelle-Laure Richardson, Gary E Sessa, Cristiana Yonemori, Kan Banerjee, Susana Leary, Alexandra Tinker, Anna V Jung, Kyung Hae Madry, Radoslaw Park, Sang-Yoon Anderson, Charles K Zohren, Fabian Stewart, Ross A Wei, Caimiao Dychter, Samuel S Monk, Bradley J